BR100 Increased By (0.23%)
BR30 Increased By (0.02%)
KSE100 Increased By (0.21%)
KSE30 Increased By (0.23%)
AGHA 6.66 Increased By ▲ 0.05 (0.76%)
BECO 4.28 Increased By ▲ 0.04 (0.94%)
BML 60.01 Decreased By ▼ -1.44 (-2.34%)
BOP 28.80 Decreased By ▼ -0.01 (-0.03%)
CNERGY 12.90 Increased By ▲ 0.10 (0.78%)
CSIL 5.68 Increased By ▲ 0.12 (2.16%)
FCCL 52.00 Increased By ▲ 0.01 (0.02%)
FFL 14.03 Increased By ▲ 0.01 (0.07%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 5.90 Decreased By ▼ -0.01 (-0.17%)
KOSM 5.41 Decreased By ▼ -0.03 (-0.55%)
LOTCHEM 25.60 Decreased By ▼ -0.22 (-0.85%)
MLCF 90.02 Decreased By ▼ -0.43 (-0.48%)
NBP 159.33 Increased By ▲ 0.06 (0.04%)
NCPL 49.25 Increased By ▲ 0.17 (0.35%)
NPL 53.20 Increased By ▲ 0.77 (1.47%)
OGDC 302.11 Decreased By ▼ -0.14 (-0.05%)
PACE 10.22 Increased By ▲ 0.36 (3.65%)
PAEL 33.62 Decreased By ▼ -0.11 (-0.33%)
PIBTL 13.80 Increased By ▲ 0.09 (0.66%)
PPL 219.86 Increased By ▲ 0.61 (0.28%)
PRL 106.85 Increased By ▲ 3.09 (2.98%)
PTC 53.21 Decreased By ▼ -1.85 (-3.36%)
SSGC 22.98 Decreased By ▼ -0.04 (-0.17%)
TBL 9.88 Increased By ▲ 0.11 (1.13%)
TELE 7.14 Decreased By ▼ -0.09 (-1.24%)
TPL 20.56 Decreased By ▼ -0.11 (-0.53%)
TPLP 11.85 Decreased By ▼ -0.02 (-0.17%)
TREET 23.70 Increased By ▲ 0.10 (0.42%)
TRG 56.55 Increased By ▲ 1.08 (1.95%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices IMF-World Bank meetings Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
World

AstraZeneca sees 2022 growth, but COVID boost to drop

Published Updated
Save
1 min
Comments
By Reuters

AstraZeneca on Thursday forecast higher 2022 sales after the drugmaker posted better-than-expected fourth-quarter profit as it gets a lift from its COVID-19 antibody treatment.

AstraZeneca China summoned over suspected fraud

The drugmaker, however, like rival GSK, warned that its gross profit margin from coronavirus products is expected to be lower than the company average for this year, while sales are expected to decline by a low-to-mid twenties percentage.

AstraZeneca GSK

Comments

Comments are closed for this article.

More Stories

Browse all stories